Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • New Therapeutic Targets in Cardiovascular Diseases (Upcoming)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI109013

Renin-Angiotensin System Inhibition in Conscious Sodium-Depleted Dogs: EFFECTS ON SYSTEMIC AND CORONARY HEMODYNAMICS

Chang-Seng Liang, Haralambos Gavras, and William B. Hood Jr.

The Department of Medicine and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

The Department of Pharmacology and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Cardiology Department of the Medical Service, Boston, Massachusetts 02118

Hypertension Department of the Medical Service, Boston, Massachusetts 02118

Thorndike Memorial Laboratories, Boston City Hospital, Boston, Massachusetts 02118

Department of Medicine, University Hospital, Boston, Massachusetts 02118

Department of Clinical Research, University Hospital, Boston, Massachusetts 02118

Find articles by Liang, C. in: JCI | PubMed | Google Scholar

The Department of Medicine and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

The Department of Pharmacology and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Cardiology Department of the Medical Service, Boston, Massachusetts 02118

Hypertension Department of the Medical Service, Boston, Massachusetts 02118

Thorndike Memorial Laboratories, Boston City Hospital, Boston, Massachusetts 02118

Department of Medicine, University Hospital, Boston, Massachusetts 02118

Department of Clinical Research, University Hospital, Boston, Massachusetts 02118

Find articles by Gavras, H. in: JCI | PubMed | Google Scholar

The Department of Medicine and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

The Department of Pharmacology and the Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118

Cardiology Department of the Medical Service, Boston, Massachusetts 02118

Hypertension Department of the Medical Service, Boston, Massachusetts 02118

Thorndike Memorial Laboratories, Boston City Hospital, Boston, Massachusetts 02118

Department of Medicine, University Hospital, Boston, Massachusetts 02118

Department of Clinical Research, University Hospital, Boston, Massachusetts 02118

Find articles by Hood, W. in: JCI | PubMed | Google Scholar

Published April 1, 1978 - More info

Published in Volume 61, Issue 4 on April 1, 1978
J Clin Invest. 1978;61(4):874–883. https://doi.org/10.1172/JCI109013.
© 1978 The American Society for Clinical Investigation
Published April 1, 1978 - Version history
View PDF
Abstract

The role of the renin-angiotensin system in the regulation of the systemic and coronary circulations during sodium depletion was studied in conscious normotensive dogs by i.v. administration of teprotide (0.5 mg/kg), an angiotensin-converting enzyme inhibitor, and saralasin (0.05-5 μg/kg per min), an angiotensin-receptor antagonist. Sodium depletion was produced by administering a low sodium diet and furosemide for 5 days. Administration of both teprotide and saralasin lowered systemic arterial blood pressure and total peripheral vascular resistance. Simultaneously, cardiac output increased, but left ventricular end-diastolic pressure, dP/dt, and dP/dt/P did not change significantly. Furthermore, both agents reduced diastolic coronary vascular resistance and increased coronary blood flow, but did not affect myocardial oxygen consumption, left ventricular work, or myocardial efficiency. These systemic and coronary vasodilator effects of teprotide and saralasin, however, were not observed in normal dogs on a regular sodium diet; in this group, the only effect noted was a slight increase in arterial pressure during saralasin infusion. Arterial plasma concentration of norepinephrine did not differ between normal and sodiumdepleted dogs, nor did it change significantly after teprotide administration. These results suggest that, during salt depletion, angiotensin II exerts an active vasoconstrictor action on the systemic and coronary vessels, but has no significant effects on myocardial contractility or energetics. It also appears likely that the increase in cardiac output observed in sodiumdepleted dogs after angiotensin inhibition was caused, at least in part, by the decrease in systemic arterial pressure.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 874
page 874
icon of scanned page 875
page 875
icon of scanned page 876
page 876
icon of scanned page 877
page 877
icon of scanned page 878
page 878
icon of scanned page 879
page 879
icon of scanned page 880
page 880
icon of scanned page 881
page 881
icon of scanned page 882
page 882
icon of scanned page 883
page 883
Version history
  • Version 1 (April 1, 1978): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts